Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 15;21(1):191.
doi: 10.1186/s12934-022-01917-y.

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity

Affiliations
Review

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity

Zi-Xu Zhang et al. Microb Cell Fact. .

Abstract

Escherichia coli, one of the most efficient expression hosts for recombinant proteins (RPs), is widely used in chemical, medical, food and other industries. However, conventional expression strains are unable to effectively express proteins with complex structures or toxicity. The key to solving this problem is to alleviate the host burden associated with protein overproduction and to enhance the ability to accurately fold and modify RPs at high expression levels. Here, we summarize the recently developed optimization strategies for the high-level production of RPs from the two aspects of host burden and protein activity. The aim is to maximize the ability of researchers to quickly select an appropriate optimization strategy for improving the production of RPs.

Keywords: Escherichia coli; Host burden; Inclusion bodies; Post-translational modification; Recombinant protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
The optimization expression strategies for T7 RNAP and pET plasmids. A Illustration of protein expression of recombinant protein genes on pET plasmids. B Optimization of T7 RNAP transcription and translation level, including substitutions of different promoters, and mutations in promoter functional region and RBS sequence. C regulation of T7 RNAP activity. The conventional approach is to utilize lysozyme or light-induction to regulate. D Optimization of pET plasmids based on expression intensity and copy numbers. Among them, the expression intensity was optimized by constructing an ITR library to screen for optimal expression results. The degree of binding of RNA-i to RNA-p determines the replication intensity of the plasmid to control the copy numbers. By constructing a promoter library for RNA-p, replacing the inducible promoter, and using dCas9 to regulate expression intensity, the copy numbers can be controlled
Fig. 2
Fig. 2
The optimization expression strategies for decoupling the cell growth and RP production. A Manipulating the expression of RNAP subunits (β and β') or inhibiting RNAP activity by RNA polymerase inhibitor GP2 to prevent transcription of endogenous growth genes. B Inhibition of growth-related gene expression using CRISPRi. C Reducing competition for host ribosome using orthologous ribosome (O-ribosome) to specifically translate target proteins. D The uncoupling strategy allows to clearly divide an RP production process into two phases, namely the growth phase and the production phase. This allows resources to be used for RP production during fermentation
Fig. 3
Fig. 3
The optimization strategies to enhance PTMs. A Principle of disulfide bond formation in the cytoplasm using the CyDisCo system. B Modification process of phosphorylation and acetylation. P: phosphonate; AC: acetyl. C Modification process of glycosylation by overexpression of a heterologous N/O-glycosylase. D Introduction of PTMs via ncAA. The figure shows the principle of phosphoserine introduction
Fig. 4
Fig. 4
The routine workflow for expression optimization based on protein properties

References

    1. Puetz J, Wurm FM. Recombinant proteins for industrial versus pharmaceutical purposes: a review of process and pricing. Processes. 2019;7:476–484. doi: 10.3390/pr7080476. - DOI
    1. Deckers M, Deforce D, Fraiture M-A, Roosens NH. Genetically modified micro-organisms for industrial food enzyme production: an overview. Foods. 2020;9:326–345. doi: 10.3390/foods9030326. - DOI - PMC - PubMed
    1. Industrial Enzymes Market. https://www.marketsandmarkets.com/Market-Reports/industrial-enzymes-mark.... Accessed Jan 2022.
    1. Walsh G. Biopharmaceutical benchmarks 2018. Nat Biotechnol. 2018;36:1136–1145. doi: 10.1038/nbt.4305. - DOI - PubMed
    1. Deo S, Turton KL, Kainth T, Kumar A, Wieden H-J. Strategies for improving antimicrobial peptide production. Biotechnol Adv. 2022:107968–84. - PubMed

MeSH terms

Substances

LinkOut - more resources